Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations. (2013)

First Author: Ingram N

Attributed to: Engineering Therapeutic Microbubbles funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/carcin/bgt222

PubMed Identifier: 23784081

Publication URI: http://europepmc.org/abstract/MED/23784081

Type: Journal Article/Review

Volume: 34

Parent Publication: Carcinogenesis

Issue: 10

ISSN: 0143-3334